90
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous and Experimental

Response to Sang-Ho Jo

, &
Pages 788-789 | Published online: 09 Jul 2009

References

  • Morcos SK, Thomsen HS, Webb JAW, and members of the contrast media safety committee of the European Society of Urogenital Radiology (ESUR). Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 1999;9:1602–13.
  • Jo S-H, Youn T-J, Koo B-K, Parl JS, Kang HJ, Cho YS, et al. Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabric (ioxaglate) in patients with renal insufficiency undergoing coronary angiography. The RECOVER study: a randomized controlled trial. J Am Coll Cardiol 2006; 48: 924–30
  • Aspelin P, Aubry P, Fransson S-G, Strasser R, Willenbrock R, Berg KJ, for the NEPHRIC Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491–9.
  • Thomsen HS, Morcos SK. Risk of contrast medium induced nephropathy in high risk patients undergoing MDCT – a pooled analysis of two randomized trials. Submitted for publication.
  • Nguyen SA, Suranyi P, Ravent JG, Randall PK, Romano PB, Storm KA, et al Iso-osmolallity versus low-osmolality iodinated contrast medium at intravenous contrast enhanced CT: effect of kidney function. Radiology 2008;248: in press.
  • Solomon R, Natarajan M, Doucet S, Harma SK, Staniloae CS, Katholi JL, et al. The cardiac-angiography in renally impaired patients (CARE) study: a randomized, double blind trial of contrast-induced nephropathy (CIN) in high risk patients. Circulation 2007; 115: 3189–96
  • Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, et al. Contrast induced nephropathy in patients with chronic kidney disease undergoing computed tomography. A double blind comparison of iodixanol and iopamidol. Invest Radiol 2006; 41: 815–21
  • Thomsen HS, Morcos SK, Erley CM, Grazioli L, Bonomo L, Ni Zhaohui, et al The ACTIVE trial: comparison of the effects on renal function of iomeprol-4000 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 2008;43:170–8.
  • Hardiek KJ, Katholi RE, Robbs RS, Katholi CE. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. J Diab Complications 2008; 22: 171–7
  • Liss P, Persson PB, Hansell P, Lagerqvist B. Renal failure in 57,925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 2006; 10: 1811–7
  • Kuhn MJ, Chen N, Sahani DV, Reimer D, van Beek EJR, Heiken JP, et al The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. Am J Roentgenol 2008;199: in press.
  • Wessely R, Koppara T, Kastrati A, Bradoric C, Schultz S, Vorpahl M, et al Iso-osmolar vs low-osmolar contrast medium in patients with impaired renal function undergoing PCI – CONTRAST. Society for Cardiovascular Angiography and Interventions Meeting (SCAI), Chicago, April 1, 2008.
  • Jingwei N, Ruiyan Z, Jiansheng Z, Xian Z, Weifeng S. Safety of isoosmolar dimer during percutaneous coronary intervention. J Interv Radiol 2006; 15: 327–9
  • Briguori C, Colombo A, Airoldi F, Mirici N, Sangiorgi GM, Violante A, et al. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Kidney Int 2006; 68: 2250–5
  • Mehran R. The ICON Trial, Transcatheter Cardiovascular Therapies Meeting (TCT). Washington DC, October 22–27, 2006.
  • DeRay G, Bellin M, Boulechfar H, Baumelou B, Koskas F, Baumelou A, et al. Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents. Am J Nephrol 1991; 11: 309–12
  • Niboshi A, Nishida M, Itoi T, Shiraishi I, Hamaoka K. Renal function and cardiac angiography. Indian J Pediatr 2006; 73: 49–52

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.